Welcome to Fresenius SE
Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Latest News
12.08.2008
Fresenius SE successfully completes capital increaseThe new Fresenius SE shares were successfully placed today. In connection with the company’s capital increase, 2,748,057 new ordinary shares were issued at a price of € 52.00 and 2,748,057 preference shares were issued at a price of € 53.00. >>>
11.08.2008
Acquisition of Dabur Pharma successfully closedFresenius Kabi has successfully closed the acquisition of Dabur Pharma Ltd. In April 2008, the company had announced the acquisition of 73.3 % of the share capital for a price of INR 76.50 per share in cash. >>>
11.08.2008
Fresenius resolves on capital increaseThe Management Board of Fresenius SE resolved today, with the consent of the Supervisory Board, to issue up to 2,748,057 new ordinary shares and up to 2,748,057 new preference shares from authorized capital without subscription rights. >>>
11.08.2008
Substantial oversubscription in first phase of syndication of US$ 2,400 million Senior Secured Credit FacilitiesAs a further component of the acquisition financing of APP Pharmaceuticals, Inc., US$ 2,400 million Senior Secured Credit Facilities were successfully offered in a first phase of syndication. >>>
30.07.2008
Fresenius Medical Care Confirms Outlook for 2008 - Reports Strong Second Quarter and Half Year Results (for additional tables see PDF-file)Fresenius Medical Care AG & Co. KGaA (“the Company”), the world’s largest provider of Dialysis Products and Services, today announced its results for the second quarter and first half of 2008. >>>